Mrna stock price with global biotech valuations under

With global biotech valuations under pressure, the "MRNA stock price" remains a focal point for growth-oriented portfolios seeking exposure to next-gen mRNA platform economics. Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company dedicated to the discovery, development, and commercialization of mRNA-based medicines and vaccines. The company received solid recognition for its COVID-19 vaccine, which was one of the first mRNA vaccines to be created and delivered worldwide. Read Also: Stock Of The Day: Will Pfizer Head Higher? Market watchers are eyeing potential FDA approval timelines as a driver for any breakout above the $100 resistance level in coming weeks.